Speaking to PEOPLE at the American Heart Association's Red Dress Collection Concert in New York City on Thursday, Jan. 30, ...
A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug ...
The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health regulator ...
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
The Rays will get a glimpse of their future in Spring Training. And that future may not be far away. The Rays announced on ...
Explore high-paying leadership roles beyond the C-suite, from senior executives to mid-management, with insights on salaries, ...
Baldwin’s standout 2024 Triple-A stint put him on the map. He came in at No. 53 in Baseball America’s Top 100 prospects, and ...
There just isn't enough room to fit all the worthy talents on MLB Pipeline's Top 100 Prospects list. We unveiled our latest ...
Homeland Security Secretary Kristi Noem announced Wednesday the department has stopped all grant funding to nonprofits that ...
The Milton Hershey boys wrestling team defeated Lebanon, 55-12, Wednesday night in a non-conference dual meet. Thanks for ...
The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain.
The Food and Drug Administration approved Vertex Pharmaceuticals’ “Journavx” on Thursday, greenlighting the non-opioid painkiller for treating moderate to severe pain in what the FDA considered the ...